Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Orion Biotechnology earns grant to support development of microbicide candidate

July 19, 2018

FDA approves Symtuza for HIV-1 infection

July 18, 2018

Chinese researchers present preclinical data for DB-213, an HIV-1 replication inhibitor

July 18, 2018

Promising data presented from completed pivotal study of PRO-140 with HAART for HIV-1

July 17, 2018

A mosaic HIV-1 vaccine is assessed in a phase I/IIa trial and in rhesus monkeys

July 17, 2018

Idenix and Merck & Co. disclose anti-HIV-1 compounds

July 16, 2018

ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine qualifies for phase II/III testing

July 16, 2018

Matinas collaborates with NINDS to develop HIV therapy based on LNC platform

July 10, 2018

Positive topline data presented from phase IIa study of ABX-464

July 4, 2018

Merck & Co. presents HIV integrase inhibitors

June 26, 2018

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...